Discussion on heart transplantation indications in patients with end-stage heart failure complicated with reversible pulmonary artery hypertension
10.3969/j.issn.1674-7445.2021.02.017
- VernacularTitle:终末期心力衰竭合并可逆性肺动脉高压患者心脏移植指征的探讨
- Author:
Shanshan ZHENG
1
;
Sheng LIU
Author Information
1. Department of Cardiac Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China
- Publication Type:Research Article
- Keywords:
Heart transplantation;
Pulmonary artery hypertension;
End-stage heart failure;
Mean pulmonary artery pressure;
Pulmonary vascular resistance;
Transpulmonary pressure gradient;
Pulmonary artery systolic pressure;
Pulmonary artery diastolic pressure
- From:
Organ Transplantation
2021;12(2):239-
- CountryChina
- Language:Chinese
-
Abstract:
Heart transplantation can save the life and improve the quality of life of patients with end-stage heart failure. Nevertheless, it is not suitable for all patients with end-stage heart failure. As a common complication of end-stage heart failure, pulmonary artery hypertension may increase the incidence of right heart failure after heart transplantation, which is associated with the short- and long-term fatality risk in the recipients after heart transplantation. In clinical practice, different transplant centers have different criteria for heart transplantation indications in patients with end-stage heart failure complicated with pulmonary artery hypertension. Accurate preoperative evaluation of surgical indications plays a critical role in determining the success of heart transplantation. In this article, the definition, pathogenesis and effects on heart transplantation, diagnostic methods and reversibility judgment of pulmonary artery hypertension, diagnostic treatment of reversible pulmonary artery hypertension and indications of heart transplantation in patients with end-stage heart failure complicated with reversible pulmonary hypertension were reviewed.
